183 related articles for article (PubMed ID: 11413356)
1. A biological staging model for operable non-small cell lung cancer.
Cox G; Jones JL; Andi A; Waller DA; O'Byrne KJ
Thorax; 2001 Jul; 56(7):561-6. PubMed ID: 11413356
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer.
Cox G; Louise Jones J; Andi A; Abrams KR; O'Byrne KJ
Lung Cancer; 2001 Dec; 34(3):417-26. PubMed ID: 11714539
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.
Cox G; Jones JL; O'Byrne KJ
Clin Cancer Res; 2000 Jun; 6(6):2349-55. PubMed ID: 10873086
[TBL] [Abstract][Full Text] [Related]
4. Towards a biological staging model for operable non-small cell lung cancer.
O'Byrne KJ; Cox G; Swinson D; Richardson D; Edwards JG; Lolljee J; Andi A; Koukourakis MI; Giatromanolaki A; Gatter K; Harris AL; Waller D; Jones JL
Lung Cancer; 2001 Dec; 34 Suppl 2():S83-9. PubMed ID: 11720747
[TBL] [Abstract][Full Text] [Related]
5. Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
Lee CY; Shim HS; Lee S; Lee JG; Kim DJ; Chung KY
J Cardiothorac Surg; 2015 Mar; 10():44. PubMed ID: 25888323
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer.
Cox G; Walker RA; Andi A; Steward WP; O'Byrne KJ
Lung Cancer; 2000 Sep; 29(3):169-77. PubMed ID: 10996419
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
Fontanini G; De Laurentiis M; Vignati S; Chinè S; Lucchi M; Silvestri V; Mussi A; De Placido S; Tortora G; Bianco AR; Gullick W; Angeletti CA; Bevilacqua G; Ciardiello F
Clin Cancer Res; 1998 Jan; 4(1):241-9. PubMed ID: 9516978
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
9. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.
Harpole DH; Richards WG; Herndon JE; Sugarbaker DJ
Ann Thorac Surg; 1996 May; 61(5):1470-6. PubMed ID: 8633961
[TBL] [Abstract][Full Text] [Related]
11. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of MMP-2 and MMP-9 expression in pathologic stage IA non-small cell lung cancer.
Shao W; Wang W; Xiong XG; Cao C; Yan TD; Chen G; Chen H; Yin W; Liu J; Gu Y; Mo M; He J
J Surg Oncol; 2011 Dec; 104(7):841-6. PubMed ID: 21721010
[TBL] [Abstract][Full Text] [Related]
13. HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer.
Brattström D; Wester K; Bergqvist M; Hesselius P; Malmström PU; Nordgren H; Wagenius G; Brodin O
Acta Oncol; 2004; 43(1):80-6. PubMed ID: 15068324
[TBL] [Abstract][Full Text] [Related]
14. Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer.
Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Whitehouse RM; Talbot DC; Gatter KC; Harris AL
Int J Cancer; 1997 Dec; 74(6):565-70. PubMed ID: 9421349
[TBL] [Abstract][Full Text] [Related]
15. Multiplexed analysis of angiogenesis and lymphangiogenesis factors predicts outcome for non-small cell lung cancer patients.
Anagnostou VK; Tiniakos DG; Fotinou M; Achimastos A; Syrigos KN
Virchows Arch; 2011 Mar; 458(3):331-40. PubMed ID: 21161269
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?
Hishida T; Yoshida J; Maeda R; Ishii G; Aokage K; Nishimura M; Nagai K
Eur J Cardiothorac Surg; 2013 Apr; 43(4):772-7. PubMed ID: 22864791
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical markers in stage I lung cancer: relevance to prognosis.
Pastorino U; Andreola S; Tagliabue E; Pezzella F; Incarbone M; Sozzi G; Buyse M; Menard S; Pierotti M; Rilke F
J Clin Oncol; 1997 Aug; 15(8):2858-65. PubMed ID: 9256129
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive value of intratumoral microvessels density in operable non-small-cell lung cancer.
Dazzi C; Cariello A; Maioli P; Solaini L; Scarpi E; Rosti G; Lanzanova G; Marangolo M
Lung Cancer; 1999 May; 24(2):81-8. PubMed ID: 10444058
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.
Noma D; Inamura K; Matsuura Y; Hirata Y; Nakajima T; Yamazaki H; Hirai Y; Ichinose J; Nakao M; Ninomiya H; Mun M; Nakagawa K; Masuda M; Ishikawa Y; Okumura S
Clin Lung Cancer; 2018 Jan; 19(1):e109-e122. PubMed ID: 29066222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
